Different Methodologies for Improving Solubility and Bioavailability
Ravinder Verma1, Deepak Kaushik1, *, Ritu Kaushik1, Vandana Singh1 1 Department of Pharmaceutical Sciences, Maharshi Dayanand University, Rohtak (Haryana), 124001, India
Abstract
Drug delivery through the oral route is perfect for both solid and liquid dosage forms. Notwithstanding numerous favorable circumstances, the improvement of the oral delivery route still speaks to an excellent test attributable to interesting curious physicochemical characteristics of lipophilic drug compounds and physiological barriers, such as gastrointestinal unsteadiness, pre-systemic metabolism and efflux pump. Upon oral intake, lipophilic drug in a dosage form is effortlessly taken by patients, passes the GIT via a tremendously versatile environment. Factors affecting solubilization are the size of particle, temperature, pressure, molecular size, nature of solute and solvent, polarity and polymorphs. Ways of enhancing oral bioavailability includeboth chemical modifications and formulation modifications. The chemical modification includes soluble pro-drug and salt formation. While formulation modification comprises of physical changes like size reduction, crystal habit modification, complexation (e.g. with β-cyclodextrin), solubilization with co-solvents or surfactants, drug dispersion with carriers (e.g. eutectic mixture, solid dispersion and polymeric carriers like micro/nanoemulsions, self-emulsifying drug delivery systems, liposomes, solid lipid nanoparticles (SLNs) and nanostructured lipid carriers which are described briefly. A formulation approach is a preferable option to chemical modification approaches which may prompt the change in chemical structure and may have an impact on the pharmacological action. Particle size reduction is classified into two categories - mechanical micronization and engineered particle size control. Mechanical micronization includes jet milling, ball milling, high-pressure homogenization. Engineered particle size control includes the cryogenic method, spray freezing onto cryogenic fluids, spray freezing into cryogenic liquids, spray freezing into vapor over liquid, ultra-rapid freezing and cryogenic spray processes. Crystal engineering includes nanocrystals, solid dispersion, co-crystal formation, sonocrystallization, liquisolid technique, self-microemulsifying drug delivery systems and inclusion complex which are discussed in detail. This chapter highlights various methods for solubility enhancements with their merits and demerits.
Keywords: Crystal engineering, Cryogenic method, High-pressure homoge-nization, Liposomes, Nanostructured lipid carriers, Oral bioavailability.
* Corresponding author Deepak Kaushik: Department of Pharmaceutical Sciences, Maharshi Dayanand University, Rohtak (Haryana), 124001, India; Tel: +91 9315809626; E-mail: [email protected] INTRODUCTION
The oral route is the most favorable route for the administration of the drug owing to its multiple benefits such as ease of administration, strong patient compliance, possibility of different release options, cost-effectiveness, self-administration, convenience for prolonged repeated use, the most valuable non-invasive and the most common route for the treatment of various diseases.
Drug delivery through the oral route is perfect for both solid and liquid dosage forms. Liquid dosage forms are noticeable because of the simplicity of administration, the precision of measurements, self-administration, pain avoidance and especially patient compliance [1].
As our human body comprises around 70% water, a drug must be soluble in aqueous GIT fluid to have adequate bioavailability. The drug present in the dosage forms discharges in gastrointestinal (GI) fluid after its breaks down that results in a solution after gentle agitation. This process is solubility dependent. The passage of the solution form of a drug across the cell lining membrane in the GI tract is permeability constrained. Then, the drug assimilates into the blood. The oral bioavailability of a drug is measured by the rate of drug solubility and permeability.
Difficulties in the Oral Drug Delivery
Notwithstanding numerous favorable circumstances, the oral drug delivery is a big challenge due to complex physicochemical characteristics of lipophilic drug compounds and physiological conditions. Gastrointestinal contents, pre-systemic metabolism, aqueous solubility, drug permeability, drug extent of dissolution and efflux pumps are some of the complex factors which affect the efficiency of drug administration through the oral route. Oral intake of lipophilic drug in a dosage form is effortlessly taken by patients, goes in GIT via a tremendously versatile environment. When a drug transits from a highly acidic pH to the digestive system, the stomach digestive enzymes and microflora alter its pH. In this perspective, the main issues of oral delivery are the physicochemical characteristics of drugs and physiological conditions of human body [2].
Oral Bioavailability
The majority of the new chemical compounds being worked on nowadays are planned to be utilized as solid dosage forms so that a viable and reproducible in vivo plasma concentration can be acquired after oral administration. In any case, poor retention and poor bioavailability do not allow oral route for intake of numerous drugs. That is why in many cases, injections are preferred for administration of such therapeutic moieties, for example, proteins and peptides due to their poor oral bioavailability that prompts high fluctuation and poor control of plasma concentrations and therapeutic effects.
The process of drug dissolution is vital for the therapeutic efficacy of the orally administered drug and route of intake. Drug dissolution includes the transfer of a solid drug into the aqueous phase in the physiological fluid. The dissolution extent of a drug is influenced by factors incorporated in the Noyes-Whitney equation [3].
Reason for Poor Oral Bioavailability
Less bioavailability is frequently connected with the drugs related to BCS II, III and IV. Drugs such as acyclovir, aspirin, atorvastatin, simvastatin, ibuprofen etc. with less water solubility and less permeability or both as are shown in Fig. (1).
There are a few reasons which are credited for poor bioavailability of drug. These components include drug properties, dosage form, solubility, acid-base characteristics, partition coefficient, large molecular size and fundamental physiology of the gastrointestinal tract (GIT). The gastrointestinal variables incorporate physiological properties of GIT fluids, gastric motility, gastric resistance time, presence of processing enzymes causing potential enzymatic degradation of the drug (e.g., cytochrome P450) and interaction with efflux transporter systems like P-glycoprotein (P-gp), poor membrane permeability and intestinal efflux properties of GIT lumen [4].
Also, the irreversible expulsion of drugs by first-pass organs, including the digestive system, liver and lungs, are other impediments of drug retention. Likewise, despite their high permeability a large portion of the new chemical entities are commonly assimilated in the upper part of the small intestinal system, retention being significantly decreased after ileum. Therefore, if these drugs are not discharged in GIT, they will have less bioavailability. In this manner, the real difficulties of the pharmaceutical industries are the identification of the methodologies that reduce the oral retention of the drugs. Drug discharge is an essential and restricting parameter for the oral bioavailability of drugs, especially for drugs with le...